2020 – 2023: ARIS L3-2622 »Biological markers of risk for development, progression and treatment response in asbestos related diseases« (PI Vita Dolžan)
2019 – 2022: ARIS J3-1753 »Molecular predictors of radiation treatment response in breast cancer« (PI: Katja Goričar)
2019 – 2022: ARIS J7-1820 »Association of glycemic variability and DNA methylation patterns with early signs of retinal and kidney damage in individuals with type 1 diabetes« (PI: Nataša Bratina)
2018 – 2021: ARIS J3-9255 »Evaluation of viral protein Nef induced extracellular vesicles as plasma biomarker of leaky HIV-1 reservoir in aviremic adults« (PI: Metka Lenassi)
2017 – 2020: ARIS L3-8203 »Serum, genetic and epigenetic markers of risk for developing, progress and treatment response in asbestos related diseases« (PI Vita Dolžan)
2016 – 2017: ARIS Z3-7198 »Identification and evaluation of novel biomarkers for residual active HIV reservoirs« (PI: Jana Ferdin)
2013 – 2016: ARIS J3-5499 »Exosome-associated Nef released from HIV infected cells contributes importantly to the development of neuroAIDS« (PI at UCSF: Matija Peterlin, PI at UL MF: Metka Lenassi)
2015 – 2016: project Teaming Artemida (Horizon 2020): »Advanced Regional Translation of Excellence into Medical Innovations for Delayed Aging« (PI: Samo Ribarič)
